NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.800
-0.080 (-2.78%)
At close: Sep 12, 2025, 4:00 PM EDT
2.840
+0.040 (1.43%)
After-hours: Sep 12, 2025, 7:50 PM EDT
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $66.56 million as of September 12, 2025. Its market cap has increased by 222.81% in one year.
Market Cap
66.56M
Enterprise Value
73.50M
1-Year Change
222.81%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since December 4, 2017, NRx Pharmaceuticals's market cap has decreased from $82.80M to $66.56M, a decrease of -19.62%. That is a compound annual growth rate of -2.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 66.56M | 150.83% |
| Dec 31, 2024 | 26.53M | -30.71% |
| Dec 29, 2023 | 38.30M | -48.99% |
| Dec 30, 2022 | 75.08M | -73.29% |
| Dec 31, 2021 | 281.11M | 328.57% |
| Dec 31, 2020 | 65.59M | 1.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |